FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157118575> ?p ?o ?g. }

• W3157118575 abstract "Multiple sclerosis (MS) is a chronic immune-mediated disease characterized by demyelination and neuroaxonal damage in the central nervous system. The etiology is complex and is still not fully understood. Accumulating evidence suggests that our gut microbiota and its metabolites influence the MS pathogenesis. Short-chain fatty acids (SCFAs), such as acetate, propionate and butyrate, are metabolites produced by gut microbiota through fermentation of indigestible carbohydrates. SCFAs and kynurenine metabolites have been shown to have important immunomodulatory properties, and propionate supplementation in MS patients has been associated with long-term clinical improvement. However, the underlying mechanisms of action and its importance in MS remain incompletely understood. We analyzed serum levels of SCFAs and performed targeted metabolomics in relation to biomarkers of inflammation, and clinical and MRI measures in newly diagnosed patients with relapsing-remitting MS before their first disease modifying therapy and healthy controls (HCs). We demonstrated that serum acetate levels were nominally reduced in MS patients compared with HCs. The ratios of acetate/butyrate and acetate/(propionate + butyrate) were significantly lower in MS patients in a multivariate analysis (orthogonal partial least squares discriminant analysis; OPLS-DA). The mentioned ratios and acetate levels correlated negatively with the pro-inflammatory biomarker IFNG, indicating an inverse relation between acetate and inflammation. In contrast, the proportion of butyrate was found higher in MS patients in the multivariate analysis, and both butyrate and valerate correlated positively with proinflammatory cytokines (IFNG and TNF), suggesting complex bidirectional regulatory properties of SCFAs. Branched SCFAs were inversely correlated with clinical disability, at a nominal significance level. Otherwise SCFAs did not correlate with clinical variables or MRI measures. There were signs of an alteration of the kynurenine pathway in MS, and butyrate was positively correlated with the immunomodulatory metabolite 3-hydroxyanthranilic acid. Other variables that influenced the separation between MS and HCs were NfL, ARG1 and IL1R1, D-ribose 5-phosphate, pantothenic acid and D-glucuronic acid. In conclusion, we provide novel results in this rapidly evolving field, emphasizing the complexity of the interactions between SCFAs and inflammation; therefore, further studies are required to clarify these issues before supplementation of SCFAs can be widely recommended." @default.
• W3157118575 created "2021-05-10" @default.
• W3157118575 creator A5003414068 @default.
• W3157118575 creator A5010254186 @default.
• W3157118575 creator A5019468970 @default.
• W3157118575 creator A5054389416 @default.
• W3157118575 creator A5072166798 @default.
• W3157118575 creator A5079060284 @default.
• W3157118575 creator A5079089874 @default.
• W3157118575 creator A5085970754 @default.
• W3157118575 creator A5088492600 @default.
• W3157118575 date "2021-05-06" @default.
• W3157118575 modified "2023-10-03" @default.
• W3157118575 title "Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls" @default.
• W3157118575 cites W1909694074 @default.
• W3157118575 cites W1941562583 @default.
• W3157118575 cites W1986440965 @default.
• W3157118575 cites W1988177479 @default.
• W3157118575 cites W1995824405 @default.
• W3157118575 cites W1996730950 @default.
• W3157118575 cites W1999906527 @default.
• W3157118575 cites W2001938165 @default.
• W3157118575 cites W2029366460 @default.
• W3157118575 cites W2030409379 @default.
• W3157118575 cites W2039907390 @default.
• W3157118575 cites W2043175749 @default.
• W3157118575 cites W2083296472 @default.
• W3157118575 cites W2094479438 @default.
• W3157118575 cites W2107277218 @default.
• W3157118575 cites W2112165124 @default.
• W3157118575 cites W2112225610 @default.
• W3157118575 cites W2122963571 @default.
• W3157118575 cites W2129016222 @default.
• W3157118575 cites W2140881278 @default.
• W3157118575 cites W2236332835 @default.
• W3157118575 cites W2256778397 @default.
• W3157118575 cites W2274927794 @default.
• W3157118575 cites W2419248649 @default.
• W3157118575 cites W2516811335 @default.
• W3157118575 cites W2563720483 @default.
• W3157118575 cites W2602832761 @default.
• W3157118575 cites W2614808368 @default.
• W3157118575 cites W2746788320 @default.
• W3157118575 cites W2756391458 @default.
• W3157118575 cites W2777074421 @default.
• W3157118575 cites W2805982252 @default.
• W3157118575 cites W2889223700 @default.
• W3157118575 cites W2901420669 @default.
• W3157118575 cites W2940158686 @default.
• W3157118575 cites W2945759983 @default.
• W3157118575 cites W2950081364 @default.
• W3157118575 cites W3003912482 @default.
• W3157118575 cites W3010923525 @default.
• W3157118575 cites W3015994133 @default.
• W3157118575 cites W3032030481 @default.
• W3157118575 cites W3037288797 @default.
• W3157118575 cites W3038389431 @default.
• W3157118575 cites W3041132435 @default.
• W3157118575 cites W3080801640 @default.
• W3157118575 cites W3087813102 @default.
• W3157118575 cites W3090814928 @default.
• W3157118575 cites W3099829251 @default.
• W3157118575 cites W3118591439 @default.
• W3157118575 cites W4211254511 @default.
• W3157118575 doi "https://doi.org/10.3389/fimmu.2021.661493" @default.
• W3157118575 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8134701" @default.
• W3157118575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34025661" @default.
• W3157118575 hasPublicationYear "2021" @default.
• W3157118575 type Work @default.
• W3157118575 sameAs 3157118575 @default.
• W3157118575 citedByCount "36" @default.
• W3157118575 countsByYear W31571185752021 @default.
• W3157118575 countsByYear W31571185752022 @default.
• W3157118575 countsByYear W31571185752023 @default.
• W3157118575 crossrefType "journal-article" @default.
• W3157118575 hasAuthorship W3157118575A5003414068 @default.
• W3157118575 hasAuthorship W3157118575A5010254186 @default.
• W3157118575 hasAuthorship W3157118575A5019468970 @default.
• W3157118575 hasAuthorship W3157118575A5054389416 @default.
• W3157118575 hasAuthorship W3157118575A5072166798 @default.
• W3157118575 hasAuthorship W3157118575A5079060284 @default.
• W3157118575 hasAuthorship W3157118575A5079089874 @default.
• W3157118575 hasAuthorship W3157118575A5085970754 @default.
• W3157118575 hasAuthorship W3157118575A5088492600 @default.
• W3157118575 hasBestOaLocation W31571185751 @default.
• W3157118575 hasConcept C100544194 @default.
• W3157118575 hasConcept C126322002 @default.
• W3157118575 hasConcept C134018914 @default.
• W3157118575 hasConcept C164027704 @default.
• W3157118575 hasConcept C185592680 @default.
• W3157118575 hasConcept C203014093 @default.
• W3157118575 hasConcept C2776706248 @default.
• W3157118575 hasConcept C2776753739 @default.
• W3157118575 hasConcept C2776914184 @default.
• W3157118575 hasConcept C2776979534 @default.
• W3157118575 hasConcept C2777503454 @default.
• W3157118575 hasConcept C2778577042 @default.
• W3157118575 hasConcept C2780014933 @default.
• W3157118575 hasConcept C2780640218 @default.
• W3157118575 hasConcept C515207424 @default.

• next